Obecne zalecenia dotyczące postępowania w zwężeniu tętnicy nerkowej a wyniki badania CORAL Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
mar 31, 2014
Słowa kluczowe:
zwężenie tętnicy nerkowej, angioplastyka tętnicy nerkowej, nadciśnienie tętnicze, niewydolność nerek, ryzyko sercowo-naczyniowe
##plugins.themes.bootstrap3.article.main##
Abstrakt
Zwężenie tętnicy nerkowej (ZTN) może być przyczyną niewydolności nerek i nadciśnienia tętniczego. Prospektywne, randomizowane badania dowiodły, że ZTN zwiększa ryzyko sercowo-naczyniowe, nerkowe i zgonu. Dotychczasowe dane pokazują, iż leczenie farmakologiczne nie jest wystarczająco skuteczne, a leczenie inwazyjne wzbudza wiele kontrowersji. Wieloośrodkowe, prospektywne badania, w tym opublikowane ostatnio badanie CORAL, nie dowiodły korzyści z rewaskularyzacji jako uzupełnienia leczenia farmakologicznego. Wyniki tych badań będą miały istotny wpływ na kształtowanie wytycznych dotyczących postępowania w ZTN.
Pobrania
Dane pobrania nie są jeszcze dostepne
##plugins.themes.bootstrap3.article.details##
Jak cytować
Artyszuk , Łukasz. (2014). Obecne zalecenia dotyczące postępowania w zwężeniu tętnicy nerkowej a wyniki badania CORAL . Kardiologia W Praktyce, 8(1), 9-16. Pobrano z https://journalsmededu.pl/index.php/kwp/article/view/1540
Numer
Dział
Artykuły
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Użycie niekomercyjne – Bez utworów zależnych 4.0 Międzynarodowe.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
Bibliografia
1. Kaatee R., Beek F.J., Verschuyl E.J. et al.: Atherosclerotic renal artery stenosis: ostial or truncal? Radiology 1996; 199(3): 637-640.
2. Safian R.D., Textor S.C.: Renal-artery stenosis. N. Engl. J. Med. 2001; 344(6): 431-442.
3. Maxwell M.H., Bleifer K.H., Franklin S.S. et al.: Cooperative study of renovascular hypertension. Demographic analysis of the study. JAMA 1972; 220(9): 1195-1204.
4. Detection, evaluation, and treatment of renovascular hypertension. Final report. Working Group on Renovascular Hypertension. Arch. Intern. Med. 1987; 147(5): 820-829.
5. Sang C.N., Whelton P.K., Hamper U. et al.: Etiologic factors of renovascular fibromuscular dysplasia: A case-controlled study. Hypertension 1989; 14: 472-479.
6. Tegtmeyer C.J., Selby J.B., Hartwell G.D. et al.: Results and complications of angioplasty in fibromuscular disease. Circulation 1991; 83(supl. I): I155-161.
7. Simon N., Franklin S.S., Bleifer K.H. et al.: Clinical characteristics of renovascular hypertension. JAMA 1972; 220(9): 1209-1218.
8. Ram C.V.: Renovascular hypertension. Curr. Opin. Nephrol. Hypertens. 1997; 6(6): 575-579.
9. Vokonas P.S., Kannel W.B., Cupples L.A.: Epidemiology and risk of hypertension in the elderly: the Framingham Study. J. Hypertens. Suppl. 1988; 6(1): S3-9.
10. Guo, H., Kalra P.A., Gilbertson D.T. et al.: Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation 2007; 115(1): 50-58.
11. Börgel J., Springer S., Ghafoor J. et al.: Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clin. Res. Cardiol. 2010; 99: 499-506.
12. Crowley J.J., Santos R.M., Peter R.H. et al.: Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am. Heart J. 1998; 136(5): 913-918.
13. Harding M.B., Smith L.R., Himmelstein S.I. et al.: Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J. Am. Soc. Nephrol. 1992; 2(11): 1608-1616.
14. Dzielinska Z., Januszewicz A., Demkow M. et al.: Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J. Hypertens. 2007; 25(3): 663-670.
15. Hansen K.J., Edwards M.S., Craven T.E. et al.: Prevalence of renovascular disease in the elderly: a population-based study. J. Vasc. Surg. 2002; 36(3): 443-451.
16. Caps M.T., Perissinotto C., Zierler R.E. et al.: Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98(25): 2866-2872.
17. Greco B.A., Breyer J.A.: The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy? Semin. Nephrol. 1996; 16(1): 2-11.
18. Goldblatt H., Lynch J., Hanzal R.F. et al.: Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 1934; 59: 69-103.
19. Goldblatt H.: The renal origin of hypertension. Physiol. Rev. 1947; 27: 120-165.
20. Harding M.B., Smith L.R., Himmelstein S.I. et al.: Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J. Am. Soc. Nephrol. 1992; 2(11): 1608-1616.
21. Edwards M.S., Craven T.E., Burke G.L. et al.: Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch. Intern. Med. 2005; 165(2): 207-213.
22. Olin J.W., Melia M., Young J.R. et al.: Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am. J. Med. 1990; 88: 46N-51N.
23. Kalra P.A., Guo H., Kausz A.T. et al.: Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005; 68(1): 293-301.
24. Dean R.H., Kieffer R.W., Smith B.M. et al.: Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch. Surg. 1981; 116(11): 1408-1415.
25. Safak E., Wilke C., Derer W. et al.: Long-term follow-up of patients with atherosclerotic renal artery disease. J. Am. Soc. Hypertens. 2013; 7(1): 24-31.
26. Conlon P.J., Athirakul K., Kovalik E. et al.: Survival in renal vascular disease. J. Am. Soc. Nephrol. 1998; 9(2): 252-256.
27. Mui KW, Sleeswijk M., van den Hout H. et al.: Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J. Am. Soc. Nephrol. 2006; 17(7): 2069-2074.
28. Chabova V., Schirger A., Stanson A.W. et al.: Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin. Proc. 2000; 75(5): 437-444.
29. Harden P.N., MacLeod M.J., Rodger R.S. et al.: Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349: 1133-1136.
30. Watson P.S., Hadjipetrou P., Cox S.V. et al.: Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000; 102: 1671-1677.
31. Burket M.W., Cooper C.J., Kennedy D.J. et al.: Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am. Heart J. 2000; 139: 64-71.
32. Lederman R.J., Mendelsohn F.O., Santos R. et al.: Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am. Heart J. 2001; 142(2): 314-323.
33. Blum U., Krumme B., Flügel P. et al.: Treatment of ostial renal-artery stenosis with vascular endoprostheses after unsuccessful balloon angioplasty. N. Engl. J. Med. 1997; 336: 459-465.
34. Dorros G., Jaff M., Mathiak L. et al.: Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998; 98(7): 642-647.
35. Leertouwer T.C., Gussenhoven E.J., Bosch J.L. et al.: Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 2000; 216(1): 78-85.
36. van de Ven P.J., Kaatee R., Beutler J.J. et al.: Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999; 353: 282-286.
37. Webster J., Marshall F., Abdalla M. et al.: Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J. Hum. Hypertens. 1998; 12: 329-335.
38. Plouin P.F., Chatellier G., Darné B. et al.: Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998; 31: 823-829.
39. van Jaarsveld B.C., Krijnen P., Pieterman H. et al.: The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N. Engl. J. Med. 2000; 342: 1007-1014.
40. Ives N.J., Wheatley K., Stowe R.L. et al.: Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol. Dial. Transplant. 2003; 18: 298-304.
41. Bax L., Woittiez A.J.J., Kouwenberg H.J. et al.: Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann. Intern. Med. 2009; 150: 840-848, W150-1.
42. Wheatley K., Ives N. et al.: ASTRAL Investigators; Revascularization versus medical therapy for renal-artery stenosis. N. Engl. J. Med. 2009; 361: 1953-1962.
43. Kane G.C., Xu N., Mistrik E. et al.: Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol. Dial. Transplant. 2010; 25: 813-820.
44. Cooper C.J., Murphy T.P., Cutlip D.E. et al.: Stenting and medical therapy for atherosclerotic renal-artery stenosis. N. Engl. J. Med. 2014; 370: 13-22.
45. Trinquart L., Mounier-Vehier C., Sapoval M. et al.: Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010; 56: 525-532.
46. Tendera M., Aboyans V., Bartelink M.L. et al.: ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur. Heart J. 2011; 32: 2851-2906.
47. Hirsch A.T., Haskal Z.J., Hertzer N.R. et al.: ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463-e654.
48. Stanowisko grupy ekspertów dotyczące diagnostyki obrazowej i wskazań do wykonywania zabiegów przezskórnej angioplastyki zwężenia tętnicy nerkowej u chorych z nadciśnieniem tętniczym przyjęte przez Polskie Towarzystwo Nadciśnienia Tętniczego, Polskie Towarzystwo Nefrologiczne. Nadciśnienie Tętnicze 2009; 13: 1-9.
2. Safian R.D., Textor S.C.: Renal-artery stenosis. N. Engl. J. Med. 2001; 344(6): 431-442.
3. Maxwell M.H., Bleifer K.H., Franklin S.S. et al.: Cooperative study of renovascular hypertension. Demographic analysis of the study. JAMA 1972; 220(9): 1195-1204.
4. Detection, evaluation, and treatment of renovascular hypertension. Final report. Working Group on Renovascular Hypertension. Arch. Intern. Med. 1987; 147(5): 820-829.
5. Sang C.N., Whelton P.K., Hamper U. et al.: Etiologic factors of renovascular fibromuscular dysplasia: A case-controlled study. Hypertension 1989; 14: 472-479.
6. Tegtmeyer C.J., Selby J.B., Hartwell G.D. et al.: Results and complications of angioplasty in fibromuscular disease. Circulation 1991; 83(supl. I): I155-161.
7. Simon N., Franklin S.S., Bleifer K.H. et al.: Clinical characteristics of renovascular hypertension. JAMA 1972; 220(9): 1209-1218.
8. Ram C.V.: Renovascular hypertension. Curr. Opin. Nephrol. Hypertens. 1997; 6(6): 575-579.
9. Vokonas P.S., Kannel W.B., Cupples L.A.: Epidemiology and risk of hypertension in the elderly: the Framingham Study. J. Hypertens. Suppl. 1988; 6(1): S3-9.
10. Guo, H., Kalra P.A., Gilbertson D.T. et al.: Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation 2007; 115(1): 50-58.
11. Börgel J., Springer S., Ghafoor J. et al.: Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clin. Res. Cardiol. 2010; 99: 499-506.
12. Crowley J.J., Santos R.M., Peter R.H. et al.: Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am. Heart J. 1998; 136(5): 913-918.
13. Harding M.B., Smith L.R., Himmelstein S.I. et al.: Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J. Am. Soc. Nephrol. 1992; 2(11): 1608-1616.
14. Dzielinska Z., Januszewicz A., Demkow M. et al.: Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J. Hypertens. 2007; 25(3): 663-670.
15. Hansen K.J., Edwards M.S., Craven T.E. et al.: Prevalence of renovascular disease in the elderly: a population-based study. J. Vasc. Surg. 2002; 36(3): 443-451.
16. Caps M.T., Perissinotto C., Zierler R.E. et al.: Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98(25): 2866-2872.
17. Greco B.A., Breyer J.A.: The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy? Semin. Nephrol. 1996; 16(1): 2-11.
18. Goldblatt H., Lynch J., Hanzal R.F. et al.: Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 1934; 59: 69-103.
19. Goldblatt H.: The renal origin of hypertension. Physiol. Rev. 1947; 27: 120-165.
20. Harding M.B., Smith L.R., Himmelstein S.I. et al.: Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J. Am. Soc. Nephrol. 1992; 2(11): 1608-1616.
21. Edwards M.S., Craven T.E., Burke G.L. et al.: Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch. Intern. Med. 2005; 165(2): 207-213.
22. Olin J.W., Melia M., Young J.R. et al.: Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am. J. Med. 1990; 88: 46N-51N.
23. Kalra P.A., Guo H., Kausz A.T. et al.: Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005; 68(1): 293-301.
24. Dean R.H., Kieffer R.W., Smith B.M. et al.: Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch. Surg. 1981; 116(11): 1408-1415.
25. Safak E., Wilke C., Derer W. et al.: Long-term follow-up of patients with atherosclerotic renal artery disease. J. Am. Soc. Hypertens. 2013; 7(1): 24-31.
26. Conlon P.J., Athirakul K., Kovalik E. et al.: Survival in renal vascular disease. J. Am. Soc. Nephrol. 1998; 9(2): 252-256.
27. Mui KW, Sleeswijk M., van den Hout H. et al.: Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J. Am. Soc. Nephrol. 2006; 17(7): 2069-2074.
28. Chabova V., Schirger A., Stanson A.W. et al.: Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin. Proc. 2000; 75(5): 437-444.
29. Harden P.N., MacLeod M.J., Rodger R.S. et al.: Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349: 1133-1136.
30. Watson P.S., Hadjipetrou P., Cox S.V. et al.: Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000; 102: 1671-1677.
31. Burket M.W., Cooper C.J., Kennedy D.J. et al.: Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am. Heart J. 2000; 139: 64-71.
32. Lederman R.J., Mendelsohn F.O., Santos R. et al.: Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am. Heart J. 2001; 142(2): 314-323.
33. Blum U., Krumme B., Flügel P. et al.: Treatment of ostial renal-artery stenosis with vascular endoprostheses after unsuccessful balloon angioplasty. N. Engl. J. Med. 1997; 336: 459-465.
34. Dorros G., Jaff M., Mathiak L. et al.: Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998; 98(7): 642-647.
35. Leertouwer T.C., Gussenhoven E.J., Bosch J.L. et al.: Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 2000; 216(1): 78-85.
36. van de Ven P.J., Kaatee R., Beutler J.J. et al.: Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999; 353: 282-286.
37. Webster J., Marshall F., Abdalla M. et al.: Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J. Hum. Hypertens. 1998; 12: 329-335.
38. Plouin P.F., Chatellier G., Darné B. et al.: Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998; 31: 823-829.
39. van Jaarsveld B.C., Krijnen P., Pieterman H. et al.: The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N. Engl. J. Med. 2000; 342: 1007-1014.
40. Ives N.J., Wheatley K., Stowe R.L. et al.: Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol. Dial. Transplant. 2003; 18: 298-304.
41. Bax L., Woittiez A.J.J., Kouwenberg H.J. et al.: Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann. Intern. Med. 2009; 150: 840-848, W150-1.
42. Wheatley K., Ives N. et al.: ASTRAL Investigators; Revascularization versus medical therapy for renal-artery stenosis. N. Engl. J. Med. 2009; 361: 1953-1962.
43. Kane G.C., Xu N., Mistrik E. et al.: Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol. Dial. Transplant. 2010; 25: 813-820.
44. Cooper C.J., Murphy T.P., Cutlip D.E. et al.: Stenting and medical therapy for atherosclerotic renal-artery stenosis. N. Engl. J. Med. 2014; 370: 13-22.
45. Trinquart L., Mounier-Vehier C., Sapoval M. et al.: Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010; 56: 525-532.
46. Tendera M., Aboyans V., Bartelink M.L. et al.: ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur. Heart J. 2011; 32: 2851-2906.
47. Hirsch A.T., Haskal Z.J., Hertzer N.R. et al.: ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463-e654.
48. Stanowisko grupy ekspertów dotyczące diagnostyki obrazowej i wskazań do wykonywania zabiegów przezskórnej angioplastyki zwężenia tętnicy nerkowej u chorych z nadciśnieniem tętniczym przyjęte przez Polskie Towarzystwo Nadciśnienia Tętniczego, Polskie Towarzystwo Nefrologiczne. Nadciśnienie Tętnicze 2009; 13: 1-9.